Transcutaneous Oximetry Systems Market

Transcutaneous Oximetry Systems Market Analysis

The Transcutaneous Oximetry Systems Market size is estimated at USD 145.83 million in 2025, and is expected to reach USD 198.02 million by 2030, at a CAGR of 6.31% during the forecast period (2025-2030).

Several factors, such as the increasing prevalence of peripheral vascular disorder and wound healing disorder, growing adoption of advanced monitoring systems for blood flow monitoring, and increasing prevalence of diabetic foot ulcers, are expected to boost market growth during the forecast period.

The rising prevalence of peripheral vascular and wound healing disorders is set to propel the growth of the transcutaneous oximetry systems market. Frequent wound-healing disorders often stem from circulatory deficiency, malnutrition, metabolic disorders, sepsis, and inflammation.

For instance, according to the Global Hunger Index, as of May 2022, about 1.5 million children under the age of five, or 45% of Somalian children, were projected to face acute malnutrition through the end of the year, including 386,400 who were expected to be severely malnourished. Thus, an increase in malnutrition leads to slow wound healing, thereby decreasing the blood oxygen level at the injury site. In such instances, transcutaneous oximetry systems are widely used for measuring oxygen levels, thereby driving the market’s growth during the forecast period.

Moreover, the rise in the utilization of transcutaneous oximetry systems in peripheral vascular disorders to detect the systems is expected to fuel market growth. For instance, an article published in November 2022 in PubMed highlighted that transcutaneous oximetry effectively detects upper limb arterial compression and related symptoms when patients with suspected thoracic outlet syndrome (TOS) perform arm abduction. These findings are expected to drive the adoption of transcutaneous oximetry systems in healthcare facilities, thereby propelling market growth.

Transcutaneous oximetry systems are increasingly utilized to assess the necessity of amputation, particularly in cases of diabetic foot ulcers, a leading cause of such procedures. For instance, an article published by the National Centre for Biotechnology Information in August 2022 highlighted that diabetic foot ulcers rank prominently among the complications faced by individuals with diabetes mellitus. These ulcers often arise from factors such as poor glycaemic control, neuropathy, peripheral vascular disease, or neglect of foot care.

In addition to the above context, approximately 60% of individuals with diabetes experience neuropathy, often resulting in foot ulcers. Globally, diabetic foot ulcers have an annual incidence ranging from 9.1 to 26.1 million cases. About 15% to 25% of all diabetes patients are at risk of developing these ulcers at some point in their lives.

Furthermore, as per 2022 updated data published by the International Diabetes Federation, about 643 million people are expected to suffer from diabetes in 2030 globally, and this number is projected to reach 784 million by 2045. Thus, the expected increase in the diabetic population raises its risk of developing diabetic foot ulcers, fueling the need to monitor any damage or blockage in the blood vessels. This is anticipated to propel the growth of the transcutaneous oximetry market during the forecast period.

Thus, the rise in peripheral vascular disorders, diabetic mellitus, and the increase in the adoption of transcutaneous oximetry systems for detecting oxygen levels in various diseases are expected to drive market growth. However, the high cost of transcutaneous oximetry systems is expected to restrain market growth.

Transcutaneous Oximetry Systems Market Trends

Preterm Births are Expected to Register High Growth During the Forecast Period

• The preterm births segment is expected to witness significant market growth due to an increase in preterm births worldwide in which premature babies in the NICU are fragile and, therefore, at risk of sudden changes in oxygenation and carbon dioxide levels. This can cause severe complications. Transcutaneous monitoring in neonates provides a real-time overview of the patient's often fluctuating oxygenation (tcpO2) and ventilation (tcpCO2) status. For instance, as per the November 2022 update by WHO, every year, an estimated 15 million babies are born preterm (before 37 completed weeks of gestation).
• Moreover, as per the article published in May 2022 in the Paediatric Medicine journal, transcutaneous oxygen monitoring and pulse oximetry were widely adopted by neonatal clinicians for many years. Even though pulse oximeters are less suitable than transcutaneous pO2 (tcpO2) monitors for detecting dangerous hyperoxemia in extremely preterm infants. This is because large changes in oxygen tension may lead to small or no changes in saturations because of the flattening of the upper part of the S-shaped oxygen dissociation curve. Thus, owing to the increase in advantages offered by the transcutaneous oxygen system in preterm births compared to other oximeters, the segment is expected to witness significant growth during the forecast period.
• Hence, an increase in preterm births and the utilization of transcutaneous oximetry systems for detecting oxygen levels in preterm births are expected to drive the segment’s growth.

North America Anticipated to Hold a Significant Market Share During the Forecast Period

• North America is expected to hold a significant market share during the forecast period due to an increase in the prevalence of peripheral vascular disorders, wound healing disorders, a rise in preterm births, and a surge in research and development in the region.
• The rising number of preterm birth cases in the United States is anticipated to fuel the need for regular monitoring of the partial pressure of oxygen or oxygen tension in preterm infants, propelling the demand for transcutaneous oximetry in the market. For instance, according to the November 2023 March of Dimes report, approximately 380,548 babies were born prematurely before 37 weeks in the United States. The report highlighted a concerning trend where black and American Indian/Alaskan Native (AI/AN) women exhibited a 54% higher likelihood of preterm birth compared to white women in the United States. Hence, the high burden of preterm births is likely to increase the demand for transcutaneous oximetry and is expected to fuel the market’s growth during the forecast period.
• Moreover, the growing prevalence of diabetes, along with an increase in spending on healthcare management, is anticipated to fuel market growth. For instance, according to the 2022 statistics published by the International Diabetes Federation, about 32 million people in the United States were living with diabetes, and this number is projected to increase to 34 million and 36 million by 2030 and 2045, respectively.
• Similarly, as per the abovementioned source, about 17 million and 21.1 million people in Mexico are expected to suffer from diabetes by 2030 and 2045, respectively. Thus, the expected high number of diabetic population increases its risk of developing severe wounds or ulcers that do not heal immediately. This is anticipated to raise the demand for transcutaneous oximetry as it is used to assess peri-wound oxygenation and microcirculatory blood flow objectively, bolstering market growth.
• Furthermore, the growing adoption of transcutaneous oximetry across healthcare facilities for monitoring wound healing and peripheral vascular diseases is anticipated to contribute to the market’s growth during the forecast period. For instance, as per the August 2022 update in the National Institute of Health, transcutaneous oximetry became increasingly popular for wound assessment and patient selection for hyperbaric oxygen therapy (HBOT) owing to its wide application as it is used for serial assessment of peri-wound oxygenation, in the diagnosis of critical limb ischemia, and the prediction of the outcome of non-healing wounds and amputation. Thus, with the increasing advantages and applications offered by transcutaneous oximetry systems, the adoption of such systems is expected to increase, which is anticipated to augment the market’s growth during the forecast period.
• Hence, the rise in diabetic mellitus, the increase in preterm births, and the growing adoption of transcutaneous oximetry systems are expected to drive market growth in North America during the forecast period.

Transcutaneous Oximetry Systems Industry Overview

The transcutaneous oximetry systems market is consolidated in nature. Market players with better distribution systems and more funds for research have established their position. Some of the players are adopting various key strategic activities such as collaboration, partnerships, and new product launches with integrated novel technologies to retain their market position. Some of the key players in the market are Perimed, SenTec AG, Radiometer, Cephalon, and Advin Health Care.

Transcutaneous Oximetry Systems Market Leaders

Transcutaneous Oximetry Systems Market News

• January 2023: Central Hospital, Nancy, France, sponsored a clinical trial to compare transcutaneous oxygen partial pressure (TcPO2) readings from the PeriFlux6000 device with oxygen saturation measurements from the IPAM device.
• February 2022: Compumedics, in collaboration with Radiometer Pacific, launched the TCM5 Flex Transcutaneous Monitor as part of Compumedic's comprehensive range of sleep diagnostic solutions. Compumedics became an official distributor of the TCM 5 Flex in Australia and New Zealand.